Les Brail
Impact in
-
- PI3K/AKT/mTOR signaling in cancer
- Hedgehog Signaling Pathway Studies
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 2
-
- PI3K/AKT/mTOR signaling in cancer 3
- Protein Degradation and Inhibitors 2
- Hedgehog Signaling Pathway Studies 2
- Co-authors
- Valérie André (3 shared papers)David S. Hong (6 shared papers)George R. Simon (2 shared papers)Jeffrey R. Infante (3 shared papers)Mayer Fishman (1 shared paper)Aejaz Nasir (1 shared paper)Razelle Kurzrock (1 shared paper)Jennifer J. Wheler (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)European Journal of Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Les Brail
18 papers receiving 422 citations
Peers
Comparison fields: 5 of 59
- Molecular Biology 323
- Oncology 108
- Immunology 75
- Genetics 29
- Cancer Research 33
Countries citing papers authored by Les Brail
This map shows the geographic impact of Les Brail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Les Brail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Les Brail more than expected).
Fields of papers citing papers by Les Brail
This network shows the impact of papers produced by Les Brail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Les Brail. The network helps show where Les Brail may publish in the future.
Co-authors
The 25 scholars most cited alongside Les Brail, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 113 | |
| 2 | 2018 | 59 | |
| 3 | 2015 | 59 | |
| 4 | 2018 | 51 | |
| 5 | 2014 | 45 | |
| 6 | 2014 | 29 | |
| 7 | 2005 | 26 | |
| 8 | 2017 | 10 | |
| 9 | 1996 | 9 | |
| 10 | 2016 | 5 | |
| 11 | 2023 | 5 | |
| 12 | 2009 | 5 | |
| 13 | 2016 | 4 | |
| 14 | 2015 | 2 | |
| 15 | 2016 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2019 | 1 |
About Les Brail
Les Brail is a scholar working on Oncology, Molecular Biology, Immunology, Genetics and Biotechnology, having authored 18 papers that have together received 427 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Research and Treatments (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Treatment and Pharmacology (2 papers), Protein Degradation and Inhibitors (2 papers), Hedgehog Signaling Pathway Studies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Molecular Biology (323 citations), Oncology (108 citations), Immunology (75 citations), Genetics (29 citations) and Cancer Research (33 citations). Les Brail has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Valérie André, David S. Hong, George R. Simon, Jeffrey R. Infante, Mayer Fishman, Aejaz Nasir, Razelle Kurzrock, Jennifer J. Wheler, Funda Meric‐Bernstam and Aung Naing. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, European Journal of Cancer and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.